Global Vaccines Innovation and Immunology Conference
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Global Vaccines Innovation and Immunology Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Global Vaccines Innovation and Immunology Conference (GVX Immunology 2026)
The Global Vaccines Innovation and Immunology Conference (also branded as GVX Immunology 2026) is a hybrid conference taking place from September 21–23, 2026. It is hosted in London, United Kingdom and also available online, enabling participation for both in-person and virtual delegates.
The conference theme is: “Building a Resilient Future Through Vaccines.” It positions vaccinology and immunology as central pillars for protecting global health, improving responses to infectious diseases, and supporting future healthcare resilience.
What the event covers
Attendees can expect a scientifically focused program covering major advancements across vaccine discovery, immune mechanisms, and next-generation technologies. The conference emphasizes both foundational vaccine science and emerging innovations, including approaches aimed at improving vaccine effectiveness, durability, and delivery.
Key areas highlighted on the official event page include:
- Vaccine Discovery, Design & Basic Science
- Fundamental Immunology & Immune Mechanisms
- Vaccine Platforms, Technologies & Adjuvants
- Novel Vaccine Delivery Systems & Formulations
- Infectious Disease Vaccines
- Non-Infectious Disease Vaccines
- Special Populations & Precision Immunization
- Translational Vaccinology & Immunoengineering
The conference also specifically notes strong interest areas around mRNA and viral vector vaccines, along with novel adjuvants and delivery systems designed to strengthen immune responses and enhance vaccine stability. In addition, the program includes attention to tackling vaccine hesitancy through community engagement and transparent communication strategies.
Who should attend
The event invites participation from researchers, industry professionals, public health officials, policymakers, and students. With the hybrid format, it is intended to support a broader global dialogue between on-site and online participants.
CPD accreditation and participation details
The conference is listed as a CPD Accredited Event with 15+ CPD credits available for participants attending and staying current with advances in the field. The official page also mentions group registration savings (registering 3+ colleagues to unlock a 20% team discount and more) as well as journal collaborations (noted as up to 50% and “Up to FREE!” on the event page).
For participation, the official page also references key internal timelines: Early Registration closes on July 15, 2026, and the Second Phase of Abstract Submission closes on July 14, 2026.
Event logistics (as stated on the official page)
Dates: September 21–23, 2026
Venue: London, United Kingdom and Online
Format: Hybrid
Theme: Building a Resilient Future Through Vaccines
Data sheet
Global Vaccines Innovation and Immunology Conference – Event Attendee & Buyer Profile Analysis
Event Date: September 21–23, 2026 |
Location: London, United Kingdom and Online |
Event Status: Upcoming |
Research Date: July 1, 2026
Event Overview
| Event Name | Global Vaccines Innovation and Immunology Conference |
| Event Date | September 21–23, 2026 |
| Event Status | Upcoming |
| Venue | Delta Hotels Heathrow Windsor, Ditton Rd, Langley, Slough SL3 8PT |
| City | London |
| State / Region | Greater London / South East England |
| Country | United Kingdom |
| Organizer | Miconferences / GVX Immunology 2026 organizing team |
| Official Event Website | vaccines.miconferences.com |
| Event Type | Hybrid scientific conference / immunology congress |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Business Services |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium to High for event identity, dates, venue, and format; Low for attendance volume because no official count was published in the provided source text. |
| Main Purpose of Event | To present research, discuss vaccine innovation and immunology, share scientific findings, support abstract submissions, and connect researchers, industry professionals, public health officials, policymakers, and students. |
About the Event
The Global Vaccines Innovation and Immunology Conference (GVX Immunology 2026) is a hybrid London-based congress focused on vaccine science, immunology, translational vaccinology, and delivery technologies. The official agenda highlights topics such as next-generation vaccine design, mRNA and viral vector vaccines, adjuvants, novel delivery systems, infectious and non-infectious disease vaccines, and strategies to address vaccine hesitancy.
This event is important for the life sciences and public health ecosystem because it brings together research, commercialization, and policy audiences in one environment. It is relevant for B2B lead generation where the target market includes vaccine developers, biotech and pharma teams, research institutions, public health bodies, contract research organizations, laboratory suppliers, clinical service providers, and solution providers supporting immunology, trial execution, and scientific collaboration.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| R&D / Scientific Leaders | Biotech, pharma, vaccine developers, research institutes | Influence on platform selection, research tools, partnerships, and collaboration | High-value audience for assay, lab, and research solution suppliers |
| Clinical Development Teams | Pharma sponsors, CROs, biotech clinical groups | Evaluates trial execution, site strategy, regulatory and data services | Relevant for CRO, eClinical, and trial operations vendors |
| Public Health Officials | National health agencies, immunization programs, public health bodies | Policy input, procurement influence, program adoption | Relevant for vaccine access, distribution, and health system support vendors |
| Regulatory / Quality Leaders | Pharma, biotech, diagnostics, medical product firms | Influence compliance, submission strategy, validation, and quality systems | Strong fit for regulatory, QA/QC, and validation service providers |
| Procurement / Supply Chain | Pharma manufacturers, hospital groups, labs, distributors | Purchasing of reagents, consumables, cold-chain, equipment, and services | Strong for supply, logistics, and laboratory procurement vendors |
| Investors / Business Development | Life sciences investors, venture capital, corporate development teams | Portfolio evaluation, partnership scouting, licensing, and diligence | Relevant for emerging biotech and platform technology providers |
| University / Academic Researchers | Universities, medical schools, research hospitals | Specifies research tools, instrumentation, and collaborative projects | Good fit for reagents, instruments, publishing, and research service suppliers |
| Students / Early Career Scientists | Postgraduate researchers, fellows, trainees | Influence future purchasing and institutional selection | Useful for brand awareness, education, and recruitment pipelines |
| Industry Partnerships / Alliances | Biotech, pharma, CROs, tech-enabled healthcare firms | Evaluates co-development, licensing, and strategic partnerships | High relevance for platform, licensing, and innovation vendors |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host City: London | Local London life sciences, academic, hospital, and policy participants | Medium | London is a major life sciences and public-sector hub with easy access to Heathrow-linked travel |
| Host Region: Greater London / South East England | Researchers, NHS-adjacent stakeholders, biotech and pharma companies | High | Strong concentration of healthcare, university, and commercial science organizations |
| Nearby Business Hubs | Oxford, Cambridge, Reading, Slough, Windsor, Stevenage | High | These corridors support biotech, pharma, research, and lab supply demand |
| National Reach: United Kingdom | UK universities, biotech firms, hospitals, public health agencies, suppliers | High | Hybrid format expands reach beyond London |
| International Reach | Europe, North America, Middle East, Asia, Africa, Latin America | High | Official site positions the congress as global and hybrid, which supports cross-border participation |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official site describes the event as a “Global Vaccines Innovation and Immunology Conference” and supports hybrid participation from international stakeholders. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| UK Health Security Agency | Government / Public Health | Vaccination, immunization, surveillance, and public health strategy relevance | gov.uk | Director, Head of Immunisation, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| NHS England | Government / Healthcare Buyer | Potential buyer for vaccine programs, service delivery, and clinical solutions | england.nhs.uk | Procurement Manager, Clinical Program Lead, Commissioning Lead | Strong Market Fit, Attendance Not Confirmed |
| The Francis Crick Institute | Research Institution | Immunology and translational science relevance | crick.ac.uk | Group Leader, Lab Manager, Research Procurement | Strong Market Fit, Attendance Not Confirmed |
| University of Oxford | Academic / Research Buyer | Vaccine, immunology, and clinical research ecosystem | ox.ac.uk | Principal Investigator, Procurement Officer, Research Administrator | Strong Market Fit, Attendance Not Confirmed |
| University of Cambridge | Academic / Research Buyer | Immunology, virology, and translational research demand | cam.ac.uk | PI, Lab Director, Research Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Imperial College London | Academic / Research Buyer | Biomedical research and vaccine science alignment | imperial.ac.uk | Department Chair, Research Manager, Purchasing Manager | Strong Market Fit, Attendance Not Confirmed |
| GSK | Pharma / Vaccine Manufacturer | Major vaccine and biologics stakeholder | gsk.com | VP Vaccines, Director R&D, Procurement Director | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharma / Biopharma | Clinical, scientific, and immunology-related product portfolio relevance | astrazeneca.com | Scientific Director, Clinical Procurement, Alliance Manager | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharma / Vaccine Manufacturer | Vaccine innovation and immunology event fit | pfizer.com | VP Research, Strategic Sourcing, External Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| Moderna | Biotech / Vaccine Developer | mRNA and vaccine platform relevance | modernatx.com | Head of Platform, Procurement, Scientific Affairs | Strong Market Fit, Attendance Not Confirmed |
| Sanofi | Pharma / Vaccine Manufacturer | Vaccines, immunology, and global public health alignment | sanofi.com | Global Procurement, Vaccines R&D, Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| BioNTech | Biotech / Vaccine Developer | Immune engineering and vaccine platform innovation | biontech.com | VP Research, Alliance Management, Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| University College London | Academic / Research Buyer | Biomedical research and immunology network relevance | ucl.ac.uk | Professor, Lab Manager, Research Procurement | Strong Market Fit, Attendance Not Confirmed |
| European Medicines Agency | Regulatory / Government | Regulatory science and vaccine oversight relevance | ema.europa.eu | Scientific Assessor, Regulatory Lead, Policy Officer | Strong Market Fit, Attendance Not Confirmed |
| World Health Organization | Global Public Health / Multilateral | Vaccine access, immunization policy, and global health coordination | who.int | Technical Officer, Program Manager, Procurement Specialist | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | VP Research / Scientific Director | R&D / Scientific Affairs | VP / Director | Owns scientific direction, collaboration, and vendor evaluation |
| 2 | Head of Vaccines / Immunology | R&D | Senior Director / Head | Directly aligned to the conference theme and purchase decisions |
| 3 | Chief Scientific Officer | Executive / Science | C-level | Shapes platform strategy, partnerships, and innovation sourcing |
| 4 | Director of Clinical Development | Clinical Development | Director | Evaluates translational and clinical execution partners |
| 5 | Procurement Manager | Procurement / Supply Chain | Manager | Buys lab supplies, services, and equipment tied to research and clinical work |
| 6 | Strategic Sourcing Manager | Procurement | Manager | Drives supplier selection and contract opportunities |
| 7 | Regulatory Affairs Director | Regulatory / Quality | Director | Important for compliance, submissions, and quality-focused vendors |
| 8 | Lab Director / Lab Manager | Laboratory Operations | Director / Manager | Purchases instruments, reagents, and consumables |
| 9 | Partnerships Director / Alliance Manager | Business Development | Director / Manager | Evaluates co-development, licensing, and sponsorship opportunities |
| 10 | Program Manager / Public Health Lead | Public Health / Programs | Manager / Director | Relevant for vaccine deployment, policy, and implementation services |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core vaccine and immunology sponsor/buyer industry | Drug development, vaccine programs, sourcing |
| 2 | Biotechnology | Strong match for innovation, platform science, and partnerships | Biotech R&D, alliances, commercialization |
| 3 | Hospital & Health Care | Hospitals and clinical networks influence vaccine uptake and research | Clinical procurement, programs, operations |
| 4 | Research | Directly aligned to conference knowledge-sharing audience | Lab services, data, instruments, publications |
| 5 | Information Technology & Services | Relevant for digital clinical workflows, research systems, and collaboration platforms | Data, cloud, analytics, event tech |
| 6 | Medical Devices | Supports delivery systems, diagnostics, and adjacent healthcare products | Instrumentation, delivery, diagnostics |
| 7 | Government Administration | Public health agencies and policy stakeholders are likely attendees | Program adoption, policy, procurement |
| 8 | Education Management | Universities and training institutions are core attendee groups | Academic research, training, procurement |
| 9 | Logistics & Supply Chain | Cold-chain, distribution, and storage are vaccine-critical | Cold chain, shipping, warehousing |
| 10 | Environmental Services | Lab safety, waste management, and compliance support | Biohazard waste, decontamination |
| 11 | Professional Training & Coaching | Training and CPD-oriented audience fit | Scientific education, certification, workshops |
| 12 | Public Policy | Vaccine access and immunization policy are central themes | Policy engagement, advocacy, advisory services |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed absence of public figure | Official website text provided | Use caution in list-sizing and audience projections |
| Exhibitor count | Not publicly confirmed | Unknown | No official exhibitor directory in provided source | Scientific congress format suggests limited or no conventional trade-show floor |
| Buyer count | Not publicly confirmed | Unknown | No official attendee list provided | Likely mixed scientific and stakeholder audience |
| Speaker count | Not publicly confirmed in supplied text | Unknown | Organizing committee listed; featured speakers section present but incomplete in supplied text | Speaker line-up may be published closer to event |
| Historical attendance | Not confirmed in provided source text | Unavailable | No prior-year attendance figure supplied | Attendance figure not publicly confirmed by the organizer. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Vaccine Innovation | New platforms, faster development, differentiated science | Meet R&D leaders and alliance teams | Platforms, reagents, development services |
| Immunology Research | Better assays, immune profiling, and mechanistic tools | Target scientific buyers and lab managers | Assays, antibodies, instrumentation |
| Clinical Translation | Bridge preclinical to clinical development | Engage clinical development and operations teams | CRO, clinical operations, data services |
| Regulatory / Quality | Compliance, validation, and submission support | Connect with regulatory and QA leadership | Regulatory consulting, QA systems |
| Cold Chain & Distribution | Storage, transport, and stability management | Speak to supply chain and logistics buyers | Packaging, logistics, temperature monitoring |
| Public Health Outreach | Vaccination adoption, hesitancy, communication | Engage policy and program stakeholders | Training, communications, program support |
| Scientific Publishing / Education | Abstracts, dissemination, CPD and education | Capture researchers and early-career attendees | Publishing, training, event education |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Direct fit for vaccine, immunology, public health, and research buyers |
| Decision-maker availability | High | Likely to include senior researchers, directors, and public health leaders |
| Data collection potential | Medium | Strong topical relevance, but no confirmed attendee list in supplied source |
| Apollo targeting potential | High | Clear industry and title segments across pharma, biotech, health, and research |
| Geographic targeting potential | High | London + UK + global hybrid reach supports broad, precise segmentation |
| Best outreach approach | Scientific thought leadership + partnership outreach | Use research relevance, abstract themes, and collaboration angles in messaging |
| Overall lead quality | High | Strong niche audience with useful buyer and influencer mix |
| Best use case | Targeted B2B attendee list building and scientific account prospecting | Useful for life sciences vendors, labs, CROs, compliance, logistics, and research services |
| Limitations / risks | No published current-year attendee list in provided text | Requires careful use of prior-year or market-fit targeting rather than attendance claims |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals, Biotechnology, Hospital & Health Care, Research, Medical Devices, Government Administration, Education Management, Logistics & Supply Chain, Information Technology & Services | Capture the most relevant scientific, clinical, and procurement buyers |
| Departments | R&D, Scientific Affairs, Clinical Development, Procurement, Supply Chain, Regulatory, Quality, Business Development, Public Health | Focus on decision-making and budget-holding functions |
| Seniority | C-level, VP, SVP, Director, Head, Senior Manager | Prioritize strategic buyers and influential stakeholders |
| Job titles | Chief Scientific Officer, VP Research, Director of Vaccines, Head of Immunology, Procurement Manager, Strategic Sourcing Manager, Lab Director, Regulatory Affairs Director, Clinical Development Director, Partnerships Director | Direct outreach to role-specific decision-makers |
| Geography | United Kingdom, Ireland, Western Europe, North America, selected APAC and MENA life sciences hubs | Match a global hybrid audience with strong UK host-market relevance |
| Employee size | 51–200, 201–500, 501–1000, 1001–5000, 5000+ | Capture both emerging innovators and large enterprise buyers |
| Keywords | vaccine, immunology, immunization, mRNA, virology, translational, adjuvant, clinical development, cold chain, public health | Refine to topic-aligned accounts and contacts |
| Technologies | LIMS, ELN, clinical trial platforms, laboratory instrumentation, data management, workflow automation | Useful for vendors selling digital and lab infrastructure |
| Revenue range | Mid-market to enterprise; prioritize funded biotech and established pharma/public institutions | Align offer size with likely budget profiles |
| Company type | Public company, private company, research institution, government agency, hospital network | Broaden coverage beyond commercial sponsors |
Suggested Apollo Search Logic: ("vaccine" OR "vaccines" OR immunology OR immunology OR immunization OR mRNA OR virology OR adjuvant OR "clinical development" OR "cold chain") AND (Director OR Head OR VP OR Manager OR Chief) within Pharmaceuticals, Biotechnology, Hospital & Health Care, Research, Government Administration, and Education Management.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Official Event Website: Vaccines Conference 2026 / GVX | Official organizer source | Event name, hybrid format, dates, London + online location, abstract deadline, CPD accreditation, topic areas | Very High |
| Provided official site text excerpt | Primary source content | Theme, participant types, abstract topics, and organizing committee names | Very High |
| Venue address reference in official event content | Venue/location reference | Venue line included in the event details supplied by the organizer content | High |
| Official event brochure / agenda links on event site | Organizer-published navigation | Confirmed presence of brochure, speakers, program, and abstract submission pages | High |
| Organizer / committee names listed on official site | Official program content | Organizing committee membership and academic affiliations | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Global Vaccines Innovation and Immunology Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds